tirzepatide which class vs. Semaglutide: What You Should Know Compounded GLP-1 - Semaglutide &

Monthly check-ins with your provider and dietitian help you get the most from treatment

Researchers proceeding despite these unknowns must accept that they are operating without the safety data that clinical trials are designed to generate

What to do: Aim for 7-9 hours of high-quality sleep per night by having a calming bedtime routine, reducing screen time before bed, or considering a sleep supplement

It targets two hormone receptors, GIP and GLP-1

The cumulative incidence was 6.7% for GLP-1 compared to 0.8% for non-GLP-1 RA over 36 months, with a hazard ratio (HR) of 7.64 (95% CI, 2.21-26.36

Tirzepatide is a dual GIP/GLP-1 receptor agonist developed by Eli Lilly and approved under the brand name Mounjaro for type 2 diabetes and Zepbound for weight management